INS and type 1 diabetes mellitus: A macroencapsulation device incorporates islets into a selectively permeable membrane which evades the immune response, whilst enabling delivery of insulin from the transplanted cells.[13, 14, 15] These macroencapsulation systems have to meet a number of stringent and challenging functional requirements in order to achieve the ultimate goal of reversing T1D.